Adding these ingredients to your meals can support appetite control, improve digestion, and help manage eating habits throughout the day
There is growing interest in exploring GLP-1 medications as promising adjunct therapies to insulin for individuals with T1D
Dublin, March 18, 2025 (GLOBE NEWSWIRE) -- The "GLP-1 Market Industry Trends and Global Forecasts to 2035, by Type of Molecule, Active Compound Used, Type of GLP-1 Agonist Drugs, Type of Agonist, Route of Administration, Target indication and Key Geographical Regions" report has been added to ResearchAndMarkets.com's offering
Generic semaglutide is not expected until at least 2031 to 2033, based on current patent expiration timelines
Medical Disclaimer The information on this page is intended for educational purposes only and does not constitute medical advice
Join us live in San Diego for our DiabetesEd Training Program Brand new agenda for 2026